consum go goe stock
despit headlin beat maintain guidanc stock weak
clearli attribut na dental consum perform includ
weak quarter vs expect well market uncertainti
creat potenti on-going pressur whether softer demand cycl
independ custom price uncertainti threat suppli constraint near-
term path forward consum trend remain somewhat murki na dental
equip dynam appear posit boon back octob
ds world given cad/cam growth anoth strong quarter
see type out-performance stock without better consum visibl
opinion challeng therefor reiter under-perform rate
slightli lower po use ev/ebitda multipl
tweak ep post-beat lower ep
maintain ep estim slightli lower
ep overal assumpt fairli unchang
slightli lower ebitda lower gm lower opex slightli lower share count due
upcom event catalyst
next catalyst like
report next week compar perform end market/competit trend
dental consum particular outsid earn expect next focu point
center around demand trend industri color updat manag
cours quarter also look addit updat increment growth
prioriti addit given compani post-spin focu
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one world largest distributor
dental medic product also provid
solut broad rang financi servic
primarili fragment custom base
compani headquart melvil new york
oper countri
under-perform rate share base
concern rel growth given softer
dental market demand tougher medic comp
multi-year share gainer
still see steadi growth across market
even loss pd dso ebit
growth harder come premium multipl
expect share lag
na equip saw growth y/i
driven organ growth na rescu acquisit
oper margin contract due employe relat cost
expect less oper margin expans due cost
associ anim health spin-off tech invest
dd growth high tech equip sale cad/cam particularli strong due
dental equip declin due difficult comp soft macro
condit australia
return growth healthi backlog australia
continu sale growth healthi backlog na equip
expect dental specialti sale run rate
affirm adj ep growth y/i
assum suppli chain disrupt coronaviru
element steadi demand servic see pressur
might see low price product
specialti small revenu profit littl greater
specialti consum growthi refin number
ye refin histor reflect specialti product includ
small portion medic specialti
independ go on-line discount soft independ market
see price shop
market rel stabl provid dso data practic
wuhan distributor ownership coronaviru impact
interest wuhan distributor materi impact bottom
saw littl acceler demand earli medic mask etc
limit suppli
flu vaccin sale strong big driver overal growth
feel good larg dso custom
innov equip
built guidanc time hard estim
saw good growth laser
 strategi next year
dental distributionse opportun add dental portfolio everi
small market share specialti area vertic integr
opportun dental specialti
area target new restructur program
everi year acquisit focus non-sal activ
price bundl valu ad servic dso
chang strategi dso market move europ
price object base ev/ebitda previous
close compani histor trade rang account less visibl
growth/margin opportun off-set demographically-posit end market
increment contribut increas technolog revenu
upsid risk po stronger expect dental consumable/equip sale
either new relationship increment primescan upgrad faster uptak
henri schein one jv cost ration downsid risk wors expect
share gain sirona-rel revenu increment pressur slowdown dental
consum growth suppli constraint relat world-wide shortag new
competit amazon creat signific growth margin pressur
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
